Thompson, Andrew G. B.
Anastasiadis, Prodromos
Druyeh, Ronald
Whitworth, Ines
Nayak, Annapurna
Nihat, Akin http://orcid.org/0000-0003-2892-1402
Mok, Tze How
Rudge, Peter
Wadsworth, Jonathan D. F. http://orcid.org/0000-0002-4797-2259
Rohrer, Jonathan
Schott, Jonathan M. http://orcid.org/0000-0003-2059-024X
Heslegrave, Amanda
Zetterberg, Henrik
Collinge, John
Jackson, Graham S.
Mead, Simon http://orcid.org/0000-0002-4326-1468
Funding for this research was provided by:
RCUK | Medical Research Council
Article History
Received: 27 July 2020
Revised: 20 January 2021
Accepted: 2 February 2021
First Online: 5 March 2021
Compliance with ethical standards
:
: JC is a Director and JC, JDFW and GSJ are shareholders of D-Gen Limited, an academic spin-out company working in the field of prion disease diagnosis, decontamination and therapeutics. HZ has served at scientific advisory boards for Denali, Roche Diagnostics, Wave, Samumed, Siemens Healthineers, Pinteon Therapeutics and CogRx, has given lectures in symposia sponsored by Fujirebio, Alzecure and Biogen, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work).